Search
for
Sort by
Research 661–690 of 1000+
- Utility of azathioprine, methotrexate and cyclosporine as steroid‐sparing agents in chronic alopecia areata: a retrospective study of continuation rates in 138 patients
- Dupilumab and Alopecia Areata: A Possible Combined or Disturbance Therapy? A Review of the Literature
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
- Local Corticosteroids for Alopecia Areata: A Narrative Review
- Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treatment for Female Androgenetic Alopecia: Review of the Literature
- Late-Onset Alopecia Areata: A Retrospective Cohort Study
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part I Topical and Device-based Treatment
- To evaluate the role of interleukin-6 in alopecia areata
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Intramuscular Corticosteroid Therapy in the Treatment of Alopecia Areata: A Time-to-Event Analysis
- How good is artificial intelligence (AI) at solving hairy problems? A review of AI applications in hair restoration and hair disorders
- Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Korean Consensus Criteria for the Severity Classification of Alopecia Areata
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms
- Immunization and Bacterial Pathogens in the Oropharynx as Risk Factors for Alopecia Areata
- Increase in IL-15 levels in patients with alopecia areata
- Stressful lie events in alopecia areata patients: A case control study
- Early prediction of alopecia areata using machine learning modeling of neuro stress immune signatures from multi datasets
- Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Clinical Manifestation of Alopecia Areata After COVID-19 Infection or Vaccination
- Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis
- Janus Kinase inhibitors in dermatology: a review
- New therapies for alopecia areata
- Metabolic syndrome in alopecia areata: an observational study at a tertiary care center